HBI
53
4
MSFT
55
2
EXPD
29
2
EXR
42
5
LRCX
56
4
TGT
35
4
TXN
29
4
AMG
33
-11
LNC
28
3
EA
41
3
AZO
46
3
STX
34
2
KLAC
45
3
LUV
45
3
CI
35
2
CA
19
6
FAST
41
7
V
70
14
GE
60
5
FE
34
4
HBI
53
4
MSFT
55
2
EXPD
29
2
EXR
42
5
LRCX
56
4
TGT
35
4
TXN
29
4
AMG
33
-11
LNC
28
3
EA
41
3
AZO
46
3
STX
34
2
KLAC
45
3
LUV
45
3
CI
35
2
CA
19
6
FAST
41
7
V
70
14
GE
60
5
FE
34
4
Financhill
Back

ATAI Life Sciences NV 10K Form

Sell
5

ATAI
ATAI Life Sciences NV

Last Price:
$1.21
Seasonality Move:
-19.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATAI News And Ratings

See the #1 stock for the next 7 days that we like better than ATAI

ATAI Financial Statistics

Sales & Book Value

Annual Sales: $314K
Cash Flow: $-19.3M
Price / Cash Flow: 0
Annual Sales: $0.87
Price / Book: 1.37

Profitability

EPS (TTM): -0.80000
Net Income (TTM): $-128.6M
Gross Margin: --
Return on Equity: -61.19%
Return on Assets: -50.08%

ATAI Life Sciences NV Earnings Forecast

Key ATAI Life Sciences NV Financial Ratios

  • The Research & Development expenses have been 19,809.87% of Revenue.
  • The Interest Expense is -6.60% of Operating Income.
  • The Net Earning history of ATAI is -12,810.19% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

ATAI Life Sciences NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ATAI
CUSIP: 00211V
Website: atai.life

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 5.81
Quick Ratio: 4.73

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATAI Technical Analysis vs Fundamental Analysis

Sell
5
ATAI Life Sciences NV (ATAI) is a Sell

Is ATAI Life Sciences NV a Buy or a Sell?